Biosintez PAO (Биосинтез ПАО) is based in Russia. The head office is in Penza. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on November 26, 1992. It currently has a total number of 972 (2024) employees. In Q3C2025, the company reported a net sales revenue drop of 9.29%. Its total assets grew by 3.53% over the same period. The enterprise’s net profit margin decreased by 0.49% in 2025.

Headquarters
Ulitsa Druzhby, Dom 4
Penza; Penza Oblast; Postal Code: 440013

Contact Details: Purchase the Biosintez PAO (Биосинтез ПАО) report to view the information.

Website: http://biosintez.com/

Basic Information

Total Employees:

Purchase the Biosintez PAO (Биосинтез ПАО) report to view the information.

Outstanding Shares:

Purchase the Biosintez PAO (Биосинтез ПАО) report to view the information.

Registered Capital:

Purchase the Biosintez PAO (Биосинтез ПАО) report to view the information.

Financial Auditors:

Purchase the Biosintez PAO (Биосинтез ПАО) report to view the information.

Incorporation Date:

November 26, 1992

Key Executives

Purchase this report to view the information.

Chairman

Purchase this report to view the information.

Chief Executive Officer

Purchase this report to view the information.

Chief Financial Officer

Ownership Details

Purchase this report to view the information.

96.96%

Subsidiaries

Penzenskaya Exportno-Importnaya Kompaniya OOO

10%

Penzenskii Gubernskii Delovoi Center OOO

9.0909%

Smo Vita OOO

1.2181%

Company Performance

Financial values in the chart are available after Biosintez PAO (Биосинтез ПАО) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.

Net sales revenue

-9.29%▼

Total Operating Revenue

-9.29%▼

Operating Profit

-31.45%▼

EBITDA

-7.32%▼

Net Profit/Loss for the Period

-13.91%▼

Total Assets

3.53%▲

Total Equity

12.92%▲

Operating Profit Margin

-5.69%▼

Net Profit Margin

-0.49%▼

Return on Equity (ROE)

-1.73%▼

Debt / Equity

-11551%▼

Quick Ratio

1036.59%▲

Cash Ratio

0.09%▲

Biosintez PAO (Биосинтез ПАО) (Russia)

Similar companies

Related EMIS Industry Reports